Cargando…

SGLT1 in pancreatic α cells regulates glucagon secretion in mice, possibly explaining the distinct effects of SGLT2 inhibitors on plasma glucagon levels

OBJECTIVES: It is controversial whether sodium glucose transporter (SGLT) 2 inhibitors increase glucagon secretion via direct inhibition of SGLT2 in pancreatic α cells. The role of SGLT1 in α cells is also unclear. We aimed to elucidate these points that are important not only for basic research but...

Descripción completa

Detalles Bibliográficos
Autores principales: Suga, Takayoshi, Kikuchi, Osamu, Kobayashi, Masaki, Matsui, Sho, Yokota-Hashimoto, Hiromi, Wada, Eri, Kohno, Daisuke, Sasaki, Tsutomu, Takeuchi, Kazusane, Kakizaki, Satoru, Yamada, Masanobu, Kitamura, Tadahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323192/
https://www.ncbi.nlm.nih.gov/pubmed/30416006
http://dx.doi.org/10.1016/j.molmet.2018.10.009
_version_ 1783385712618373120
author Suga, Takayoshi
Kikuchi, Osamu
Kobayashi, Masaki
Matsui, Sho
Yokota-Hashimoto, Hiromi
Wada, Eri
Kohno, Daisuke
Sasaki, Tsutomu
Takeuchi, Kazusane
Kakizaki, Satoru
Yamada, Masanobu
Kitamura, Tadahiro
author_facet Suga, Takayoshi
Kikuchi, Osamu
Kobayashi, Masaki
Matsui, Sho
Yokota-Hashimoto, Hiromi
Wada, Eri
Kohno, Daisuke
Sasaki, Tsutomu
Takeuchi, Kazusane
Kakizaki, Satoru
Yamada, Masanobu
Kitamura, Tadahiro
author_sort Suga, Takayoshi
collection PubMed
description OBJECTIVES: It is controversial whether sodium glucose transporter (SGLT) 2 inhibitors increase glucagon secretion via direct inhibition of SGLT2 in pancreatic α cells. The role of SGLT1 in α cells is also unclear. We aimed to elucidate these points that are important not only for basic research but also for clinical insight. METHODS: Plasma glucagon levels were assessed in the high-fat, high-sucrose diet (HFHSD) fed C57BL/6J mice treated with dapagliflozin or canagliflozin. RT-PCR, RNA sequence, and immunohistochemistry were conducted to test the expression of SGLT1 and SGLT2 in α cells. We also used αTC1 cells and mouse islets to investigate the molecular mechanism by which SGLT1 modulates glucagon secretion. RESULTS: Dapagliflozin, but not canagliflozin, increased plasma glucagon levels in HFHSD fed mice. SGLT1 and glucose transporter 1 (GLUT1), but not SGLT2, were expressed in αTC1 cells, mouse islets and human islets. A glucose clamp study revealed that the plasma glucagon increase associated with dapagliflozin could be explained as a response to acute declines in blood glucose. Canagliflozin suppressed glucagon secretion by inhibiting SGLT1 in α cells; consequently, plasma glucagon did not increase with canagliflozin, even though blood glucose declined. SGLT1 effect on glucagon secretion depended on glucose transport, but not glucose metabolism. Islets from HFHSD and db/db mice displayed higher SGLT1 mRNA levels and lower GLUT1 mRNA levels than the islets from control mice. These expression levels were associated with higher glucagon secretion. Furthermore, SGLT1 inhibitor and siRNA against SGLT1 suppressed glucagon secretion in isolated islets. CONCLUSIONS: These data suggested that a novel mechanism regulated glucagon secretion through SGLT1 in α cells. This finding possibly explained the distinct effects of dapagliflozin and canagliflozin on plasma glucagon levels in mice.
format Online
Article
Text
id pubmed-6323192
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-63231922019-01-18 SGLT1 in pancreatic α cells regulates glucagon secretion in mice, possibly explaining the distinct effects of SGLT2 inhibitors on plasma glucagon levels Suga, Takayoshi Kikuchi, Osamu Kobayashi, Masaki Matsui, Sho Yokota-Hashimoto, Hiromi Wada, Eri Kohno, Daisuke Sasaki, Tsutomu Takeuchi, Kazusane Kakizaki, Satoru Yamada, Masanobu Kitamura, Tadahiro Mol Metab Original Article OBJECTIVES: It is controversial whether sodium glucose transporter (SGLT) 2 inhibitors increase glucagon secretion via direct inhibition of SGLT2 in pancreatic α cells. The role of SGLT1 in α cells is also unclear. We aimed to elucidate these points that are important not only for basic research but also for clinical insight. METHODS: Plasma glucagon levels were assessed in the high-fat, high-sucrose diet (HFHSD) fed C57BL/6J mice treated with dapagliflozin or canagliflozin. RT-PCR, RNA sequence, and immunohistochemistry were conducted to test the expression of SGLT1 and SGLT2 in α cells. We also used αTC1 cells and mouse islets to investigate the molecular mechanism by which SGLT1 modulates glucagon secretion. RESULTS: Dapagliflozin, but not canagliflozin, increased plasma glucagon levels in HFHSD fed mice. SGLT1 and glucose transporter 1 (GLUT1), but not SGLT2, were expressed in αTC1 cells, mouse islets and human islets. A glucose clamp study revealed that the plasma glucagon increase associated with dapagliflozin could be explained as a response to acute declines in blood glucose. Canagliflozin suppressed glucagon secretion by inhibiting SGLT1 in α cells; consequently, plasma glucagon did not increase with canagliflozin, even though blood glucose declined. SGLT1 effect on glucagon secretion depended on glucose transport, but not glucose metabolism. Islets from HFHSD and db/db mice displayed higher SGLT1 mRNA levels and lower GLUT1 mRNA levels than the islets from control mice. These expression levels were associated with higher glucagon secretion. Furthermore, SGLT1 inhibitor and siRNA against SGLT1 suppressed glucagon secretion in isolated islets. CONCLUSIONS: These data suggested that a novel mechanism regulated glucagon secretion through SGLT1 in α cells. This finding possibly explained the distinct effects of dapagliflozin and canagliflozin on plasma glucagon levels in mice. Elsevier 2018-10-27 /pmc/articles/PMC6323192/ /pubmed/30416006 http://dx.doi.org/10.1016/j.molmet.2018.10.009 Text en © 2018 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Suga, Takayoshi
Kikuchi, Osamu
Kobayashi, Masaki
Matsui, Sho
Yokota-Hashimoto, Hiromi
Wada, Eri
Kohno, Daisuke
Sasaki, Tsutomu
Takeuchi, Kazusane
Kakizaki, Satoru
Yamada, Masanobu
Kitamura, Tadahiro
SGLT1 in pancreatic α cells regulates glucagon secretion in mice, possibly explaining the distinct effects of SGLT2 inhibitors on plasma glucagon levels
title SGLT1 in pancreatic α cells regulates glucagon secretion in mice, possibly explaining the distinct effects of SGLT2 inhibitors on plasma glucagon levels
title_full SGLT1 in pancreatic α cells regulates glucagon secretion in mice, possibly explaining the distinct effects of SGLT2 inhibitors on plasma glucagon levels
title_fullStr SGLT1 in pancreatic α cells regulates glucagon secretion in mice, possibly explaining the distinct effects of SGLT2 inhibitors on plasma glucagon levels
title_full_unstemmed SGLT1 in pancreatic α cells regulates glucagon secretion in mice, possibly explaining the distinct effects of SGLT2 inhibitors on plasma glucagon levels
title_short SGLT1 in pancreatic α cells regulates glucagon secretion in mice, possibly explaining the distinct effects of SGLT2 inhibitors on plasma glucagon levels
title_sort sglt1 in pancreatic α cells regulates glucagon secretion in mice, possibly explaining the distinct effects of sglt2 inhibitors on plasma glucagon levels
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323192/
https://www.ncbi.nlm.nih.gov/pubmed/30416006
http://dx.doi.org/10.1016/j.molmet.2018.10.009
work_keys_str_mv AT sugatakayoshi sglt1inpancreaticacellsregulatesglucagonsecretioninmicepossiblyexplainingthedistincteffectsofsglt2inhibitorsonplasmaglucagonlevels
AT kikuchiosamu sglt1inpancreaticacellsregulatesglucagonsecretioninmicepossiblyexplainingthedistincteffectsofsglt2inhibitorsonplasmaglucagonlevels
AT kobayashimasaki sglt1inpancreaticacellsregulatesglucagonsecretioninmicepossiblyexplainingthedistincteffectsofsglt2inhibitorsonplasmaglucagonlevels
AT matsuisho sglt1inpancreaticacellsregulatesglucagonsecretioninmicepossiblyexplainingthedistincteffectsofsglt2inhibitorsonplasmaglucagonlevels
AT yokotahashimotohiromi sglt1inpancreaticacellsregulatesglucagonsecretioninmicepossiblyexplainingthedistincteffectsofsglt2inhibitorsonplasmaglucagonlevels
AT wadaeri sglt1inpancreaticacellsregulatesglucagonsecretioninmicepossiblyexplainingthedistincteffectsofsglt2inhibitorsonplasmaglucagonlevels
AT kohnodaisuke sglt1inpancreaticacellsregulatesglucagonsecretioninmicepossiblyexplainingthedistincteffectsofsglt2inhibitorsonplasmaglucagonlevels
AT sasakitsutomu sglt1inpancreaticacellsregulatesglucagonsecretioninmicepossiblyexplainingthedistincteffectsofsglt2inhibitorsonplasmaglucagonlevels
AT takeuchikazusane sglt1inpancreaticacellsregulatesglucagonsecretioninmicepossiblyexplainingthedistincteffectsofsglt2inhibitorsonplasmaglucagonlevels
AT kakizakisatoru sglt1inpancreaticacellsregulatesglucagonsecretioninmicepossiblyexplainingthedistincteffectsofsglt2inhibitorsonplasmaglucagonlevels
AT yamadamasanobu sglt1inpancreaticacellsregulatesglucagonsecretioninmicepossiblyexplainingthedistincteffectsofsglt2inhibitorsonplasmaglucagonlevels
AT kitamuratadahiro sglt1inpancreaticacellsregulatesglucagonsecretioninmicepossiblyexplainingthedistincteffectsofsglt2inhibitorsonplasmaglucagonlevels